Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry

Volumn 65, Issue 7, 2009, Pages 564-570

  Cheon, Keun Ah ^a,c   Cho, Dae Yeon ^b   Koo, Min Seong ^c   Song, Dong Ho ^a   Namkoong, Kee ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Doo San Engineering Center   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

ADHD; ADRA2A; G allele; methylphenidate; response

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; GENOMIC DNA; METHYLPHENIDATE;

ALLELE; ALPHA 2A ADRENERGIC RECEPTOR GENE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CORRELATION ANALYSIS; DNA POLYMORPHISM; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MECHANISM; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SCHOOL CHILD; SOUTH KOREA; TREATMENT RESPONSE;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HOMOZYGOTE; HUMANS; KOREA; MALE; METHYLPHENIDATE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 61549118495     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.12.003     Document Type: Article

References (48)

1. Faraone S.V., Biederman J., Spencer T., Wilens T., Seidman L.J., Mick E., et al. Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry 48 (2000) 9-20
2. Biederman J., Faraone S.V., and Monuteaux M.C. Differential effect of environmental adversity by gender: Rutter's index of adversity in a group of boys and girls with and without ADHD. Am J Psychiatry 159 (2002) 1556-1562
3. Kent L. Recent advances in the genetics of attention deficit hyperactivity disorder. Curr Psychiatry Rep 6 (2004) 143-148
4. Todd R.D., Joyner C.A., Ji T.H., Sun L., Reich W., and Neuman R.J. Family factors and sampling approach differentially influence attention deficit/hyperactivity disorder subtypes. Mol Psychiatry 9 (2004) 260-263
5. Rietveld M.J., Hudziak J.J., Bartels M., van Beijsterveldt C.E., and Boomsma D.I. Heritability of attention problems in children: Longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry 45 (2004) 577-588
6. Moore J., and Fombonne E. Psychopathology in adopted and nonadopted children: A clinical sample. Am J Orthopsychiatry 69 (1999) 403-409
7. Levy F., Hay D.A., McStephen M., Wood C., and Waldman I. Attention-deficit hyperactivity disorder: A category or a continuum?. Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36 (1997) 737-744
8. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Blake H., et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 58 (2000) 31-40
9. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes-DRD2, D beta H, and DAT1. Am J Med Genet 67 (1996) 264-288
10. Comings D.E., Gonzalez N.S., Cheng Li S.C., and MacMurray J. A "line item" approach to the identification of genes involved in polygenic behavioral disorders: The adrenergic alpha2A (ADRA2A) gene. Am J Med Genet B Neuropsychiatr Genet 118 (2003) 110-114
11. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., and Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
12. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res 94 (1998) 127-152
13. Volkow N.D., Wang G.J., Fowler J.S., and Ding Y.S. Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1410-1415
14. Pliszka S.R., McCracken J.T., and Maas J.W. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives. J Am Acad Child Adolesc Psychiatry 35 (1996) 264-272
15. Arnsten A.F., Steere J.C., and Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53 (1996) 448-455
16. Arnsten A.F., and Li B.M. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57 (2005) 1377-1384
17. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60 (2006) 1111-1120
18. Andrews G.D., and Lavin A. Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors. Neuropsychopharmacology 31 (2006) 594-601
19. Biederman J., Spencer T., and Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 7 (2004) 77-97
20. Spencer T., and Biederman J. Non-stimulant treatment for attention-deficit/hyperactivity disorder. J Atten Disord 6 suppl 1 (2002) S109-S119
21. Lario S., Calls J., Cases A., Oriola J., Torras A., and Rivera F. MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. Clin Genet 51 (1997) 129-130
22. Park L., Nigg J.T., Waldman I.D., Nummy K.A., Huang-Pollock C., Rappley M., et al. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10 (2005) 572-580
23. Comings D.E., Gade-Andavolu R., Gonzalez N., Blake H., Wu S., and MacMurray J.P. Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 55 (1999) 160-172
24. Xu C., Schachar R., Tannock R., Roberts W., Malone M., Kennedy J.L., et al. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 105 (2001) 159-162
25. Roman T., Schmitz M., Polanczyk G.V., Eizirik M., Rohde L.A., and Hutz M.H. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?. Am J Med Genet B Neuropsychiatr Genet 120 (2003) 116-120
26. Stevenson J., Langley K., Pay H., Payton A., Worthington J., Ollier W., et al. Attention deficit hyperactivity disorder with reading disabilities: Preliminary genetic findings on the involvement of the ADRA2A gene. J Child Psychol Psychiatry 46 (2005) 1081-1088
27. Wang B., Wang Y., Zhou R., Li J., Qian Q., Yang L., et al. Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 130-134
28. Schmitz M., Denardin D., Silva T.L., Pianca T., Roman T., Hutz M.H., et al. Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry 60 (2006) 1028-1033
29. Roman T., Polanczyk G.V., Zeni C., Genro J.P., Rohde L.A., and Hutz M.H. Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. Mol Psychiatry 11 (2006) 8-10
30. Weinshilboum R. Inheritance and drug response. N Engl J Med 348 (2003) 529-537
31. Sergeant J. Are we ready for endophenotypes in attention deficit hyperactivity disorder?. Rev Bras Psiquiatr 27 (2005) 262-263
32. Polanczyk G., Zeni C., Genro J.P., Roman T., Hutz M.H., and Rohde L.A. Attention-deficit/hyperactivity disorder: Advancing on pharmacogenomics. Pharmacogenomics 6 (2005) 225-234
33. Cheon K.A., Kim B.N., and Cho S.C. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Neuropsychopharmacology 32 (2007) 1377-1383
34. Yang L., Wang Y.F., Li J., and Faraone S.V. Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry 43 (2004) 1154-1158
35. Polanczyk G., Zeni C., Genro J.P., Guimaraes A.P., Roman T., Hutz M.H., et al. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64 (2007) 218-224
36. da Silva T.L., Pianca T.G., Roman T., Hutz M.H., Faraone S.V., Schmitz M., et al. Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type. J Neural Transm 115 (2008) 341-345
37. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 (1997) 980-988
38. Kim Y.S., Cheon K.A., Kim B.N., Chang S.A., Yoo H.J., Kim J.W., et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K). Yonsei Med J 45 (2004) 81-89
39. DuPaul G., Power T., Anastopoulos A., and Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation (1998), Guilford Press, New York
40. National Institute of Mental Health. CGI, Clinical Global Impressions. In: Guy W., and Bonato R. (Eds). Manual of the ECDEU Assessment Battery, revised edition (1970), National Institute of Mental Health, Chevy Chase, Maryland
41. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46 (2007) 894-921
42. Roman T., Szobot C., Martins S., Biederman J., Rohde L.A., and Hutz M.H. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12 (2002) 497-499
43. Cheon K.A., Ryu Y.H., Kim J.W., and Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15 (2005) 95-101
44. Roman T., Schmitz M., Polanczyk G., Eizirik M., Rohde L.A., and Hutz M.H. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 105 (2001) 471-478
45. Lasky-Su J., Lange C., Biederman J., Tsuang M., Doyle A.E., Smoller J.W., et al. Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals. Am J Med Genet B Neuropsychiatr Genet 147B (2008) 100-106
46. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa, New Jersey 365-386
47. Belfer I., Buzas B., Hipp H., Phillips G., Taubman J., Lorincz I., et al. Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. J Hum Genet 50 (2005) 12-20
48. Lage M., and Hwang P. Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment. J Child Adolesc Psychopharmacol 14 (2004) 575-581